Services
Besides the top priority influenza vaccine manufacturing Fluart offers different GMP-grade services to promote its partners scientific activity to address their challenges effectively. These tailor-made services include production activities, quality control, logistics and complete documentation.
Contract development and manufacturing (CDMO) services for every stage of your drug development journey.
Intercultural cooperation by transferring vaccine technology and strengthening cooperation with national regulatory authorities.
Use of bacteriophages
Bacteriophages are the viruses of the bacteria. They specifically and effectively destroy the target bacteria. The bacteriophage therapy can be applied efficiently and widely to actively treat the infections caused by different bacteria. Bacteriophages have further utilisation benefit: in case a bacterium is partially sensitive for antibiotics the bacteriophages can be applied as a complementary therapy to increase efficiency of the treatment. Further, this therapy ensures a rapid and cost-effective solution against newly emerging resistant and multi-resistant bacterial strains and their mutations, as well.
Our research achievements
Our company’s aim was back in 2017 to develop a bacteriophage active substance-based product(s) which is suitable to fight against the Salmonella both in human and veterinary fields of application. In the last decades the salmonellosis has become the most significant infectious disease faced by the public health. As a result of our development today we possess an active substance containing bacteriophages effective against Salmonella infantis bacterium. This substance has been registered with EMA under number …… The manufacturing technology has been developed to be able to produce effective cocktails and active substances with broad spectrum of effects to be used both in human and veterinary applications.
Our advantages
Our pharmaceutical manufacturing experience and professional background, as well as the developed manufacturing technology together enable the rapid and effective reaction against the variable bacterial environment. Further, our technology meets the requirements of the newly introduced veterinary regulations by EMA, as well as of the human GMP regulations.
PARTNER WITH US
Let's Make Healthier Future Happen, Together
Whether you aim to progress an idea, Fluart is by your side throughout the entire process.